ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Concerta 36 mg, Retardtabletten - 30 Tablette(n)
56249022 Janssen-Cilag AG
Concerta 36 mg, Retardtabletten31.07.2003
Original31.07.2003
Methylphenidate (N06BA04)03.04.2007
WHO-DDD 
01.10.20.30 Tablette(n)
01.10.20. 
A+  
Yes 
IPCI
41.75Yes
    
10 %61.60
7680562490223SynthetikaA
2687231 
Composition
methylphenidati hydrochloridum 36 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum K 29-32, acidum succinicum, acidum stearicum, E 321, E 172 (flavum), E 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 16.7 mg, hypromellosum, E 171, triacetinum, macrogolum 400, cera carnauba, Drucktinte: E 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto.
Packungsbestandteile
Retard-Tabletten 
 
Active AgentDose
Methylphenidat Hydrochlorid36 mg
BAG: Active AgentDose
Methylphenidat Hydrochlorid36 mg
 
Inactive agentsDoseadditional_information
   
   
Acidum Phosphoricum Concentrat  
   
Succinsäure  
   
   
  color.
  Drucktinte
   
Hypromellosum  
Lactose Monohydrat Überzug
Macrogol400  
Natrium Chlorid  
Poloxamer188  
 29-32 
   
Propylenglycol  
   
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home